RCVRN and breast carcinoma: In this cohort of TULP1 seropositive patients in women with breast cancer (n = 36/90), anti-recoverin (n = 12/90) and anti-Rab6 (n = 13/90) AAbs were found to be present along, with anti-TULP1, in the same patient.